financetom
Business
financetom
/
Business
/
Are Zomato shares overpriced? Valuation guru Aswath Damodaran pegs it at Rs 41
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Are Zomato shares overpriced? Valuation guru Aswath Damodaran pegs it at Rs 41
Jul 23, 2021 5:22 AM

Zomato was listed on the National Stock Exchange today after the allotment of shares was finalised post the stellar IPO. The shares of the company opened at Rs 116, a 52.63 percent premium over its final offer price of Rs 76, mostly due to huge demand from investors. The company’s IPO was subscribed to over 38 times.

Share Market Live

NSE

The market capitalisation of the company crossed Rs one lakh crore mark, as it stood at Rs 1,08,067.35 crore.

The start-up saw the biggest IPO ever in Indian markets. But as the price reached a high of Rs 138.90, almost double the offer price, many investors wondered whether the company was worth it.

Academician Aswath Damodaran said that the shares are currently overpriced and are “worth Rs 41”.

Damodaran calculated the share price based on the valuation of the company and its underlying business model.

“With my upbeat story of growth and profitability, the value that I derive for equity is close to 394 billion INR (about $5.25 billion), translating into a value per share of Rs 41.”

Damodaran, a Professor of Finance at the Stern School of Business at New York University, has been called the “Dean of Valuation”, and is one of the biggest experts on corporate valuation. He has written several books on equity valuation and corporate finance.

“Zomato is a money-losing, cash-burning enterprise now, but it has immense market potential and is on track to delivering on a viable business model. It will face plenty of challenges on that path, both at the micro-level (management, competition) and at the macro-level (economic and political developments in India),” Damodaran said.

“I believe that the company is currently overpriced, given its potential, but I would have no qualms about investing in the stock, if the price drops in the near future, with the full understanding that this is a joint wager on a company, a sector, and a country,” he added.

While Damodaran suggested that the company is overvalued currently, still in a cash-burning, zero-profit system, others feel that Zomato will be a good bet in the long term.

Damodaran’s full analysis can be found on his blog.

First Published:Jul 23, 2021 2:22 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fintech Ramp secures $22.5 billion valuation in late-stage funding round
Fintech Ramp secures $22.5 billion valuation in late-stage funding round
Jul 30, 2025
(Reuters) -Fintech Ramp said on Wednesday it had raised $500 million at a valuation of $22.5 billion in a late-stage funding round led by investment firm ICONIQ. Ramp offers corporate cards, payment services and expense management applications. The move comes just over a month after the company secured a $16 billion valuation in a Series E funding round. The latest...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Top Premarket Decliners
Top Premarket Decliners
Jul 30, 2025
07:59 AM EDT, 07/30/2025 (MT Newswires) -- Cardiff Oncology ( CRDF ) shares were 24% lower pre-bell Wednesday, extending Tuesday's slide. ProPetro ( PUMP ) stock was down 12% after the company reported a wider Q2 loss amid lower revenue. Anike Therapeutics (ANIK) shares were 9% lower after the company posted weaker Q2 financial results. ...
Scotts Miracle-Gro Fiscal Q3 Adjusted Earnings Rise, Sales Fall; Full-Year EPS Guidance Reaffirmed
Scotts Miracle-Gro Fiscal Q3 Adjusted Earnings Rise, Sales Fall; Full-Year EPS Guidance Reaffirmed
Jul 30, 2025
07:58 AM EDT, 07/30/2025 (MT Newswires) -- Scotts Miracle-Gro ( SMG ) reported fiscal Q3 non-GAAP net income Wednesday of $2.59 per diluted share, up from $2.31 a year earlier. Analysts polled by FactSet expected $2.26. Net sales for the quarter ended June 28 were $1.19 billion, down from $1.20 billion a year earlier. Analysts surveyed by FactSet expected $1.23...
Copyright 2023-2026 - www.financetom.com All Rights Reserved